Inter-tumor validation, through advanced MRI and circulating biomarkers, of plasma Tie2 as the vascular response biomarker for bevacizumab.

Gordon C. Jayson, Cong Zhou, Laura Hope Horsley, Kalena Marti, Danielle Shaw, Nerissa Mescallado, Andrew R. Clamp, Mark P. Saunders, Juan W. Valle, Alison Catherine Backen, Kathryn Simpson, Ross Little, Yvonne Watson, Susan Cheung, Caleb Roberts, Prakash Manoharan, Alan Jackson, James O'Connor, Geoff J. M. Parker, Caroline Dive

Research output: Contribution to journalArticlepeer-review

Cite this